There are currently two major classes of drugs available in China for the antiviral treatment of patients with chronic hepatitis B: interferons and nucleoside (acid) analogs. Different drugs have different indications and different patients have different needs, so the choice of medication needs to be made according to the condition of different patients and combined with their treatment needs. In general, those who are younger than 40 years old, have low HBVDNA viral index values, high ALT values in liver function (500 U/ML or more), no substantial liver damage, and no other intercurrent diseases are preferred to interferon therapy. The rest can be considered for oral treatment with nucleoside analogues, with the aim of being able to control the progression of the disease and guarantee the quality of life. However, it should be emphasized here that you should see a physician to make your choice of antiviral therapy and let an experienced physician make the choice for you.